About Us
Forget what you thought you knew about NGS targeting workflows.
Our Mission
We deliver targeted NGS technology that works and is easy to use. Our simple solutions will accelerate innovation and make genetic testing even more accessible. Easy on your staff. Simplifying the lab.
Molecular Loop’s patented technology was developed over many years to enable high-accuracy, ultra high-throughput NGS sequencing solutions for clinical applications and large-scale research projects. We specialize in developing production-grade chemistry that simplifies the workflow, reduces cost and time, significantly increases throughput, and delivers high-quality results. The technology has been used extensively in clinical studies and has a strong publication record.
Our Team
NGS veterans with battle-hardened and field-tested technology
Greg Porreca, Ph.D.
Co-founder, President & CEO
Eric Boyden, Ph.D.
Co-founder and Chief Scientific Officer
Pat Saunders
Chief Operating Officer
Lindsay Wold
Vice President of Sales
Vanessa Weisman
Controller
Jack Amaral
Senior Production Technologist
Joe Vieira
Head of Engineering
Kelly Glibas
NGS Sales Specialist
Danielle Bodnar
Senior NGS Sales Specialist
Arjun Patel
Bioinformatics Analyst
Marelize du Toit
Director of Product
Matt Parisi
VP of Operations
Publications
Porreca, G. J., K. Zhang, J. B. Li, B. Xie, D. Austin, S. L. Vassallo, E. M. LeProust et al. “Multiplex amplification of large sets of human exons.” Nature methods 4, no. 11 (2007): 931-936.
Umbarger, M. A., C. J. Kennedy, P. Saunders, B. Breton, N. Chennagiri, J. Emhoff, V. Greger et al. “Next-generation carrier screening.” Genetics in Medicine 16, no. 2 (2014): 132-140.
Hallam, Stephanie, et al. “Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing.” The Journal of Molecular Diagnostics 16, no. 2 (2014): 180-189.
